Tactile Systems Technology (TCMD) Net Income towards Common Stockholders Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn | 40.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.72% |
| Dec 31, 2025 | 96.26% |
| Sep 30, 2025 | 59.24% |
| Jun 30, 2025 | -24.73% |
| Mar 31, 2025 | -34.63% |
| Dec 31, 2024 | 18.92% |
| Sep 30, 2024 | -76.87% |
| Jun 30, 2024 | 5,442.50% |
| Mar 31, 2024 | -17.13% |
| Dec 31, 2023 | 77.65% |
| Sep 30, 2023 | 1,077.84% |
| Jun 30, 2023 | 98.28% |
| Mar 31, 2023 | 87.89% |
| Dec 31, 2022 | 161.65% |
| Sep 30, 2022 | 32.07% |
| Jun 30, 2022 | -455.56% |
| Mar 31, 2022 | -587.03% |
| Dec 31, 2021 | -161.88% |
| Sep 30, 2021 | -238.41% |
| Jun 30, 2021 | 109.42% |
| Mar 31, 2021 | -73.37% |
| Dec 31, 2020 | 182.82% |
| Sep 30, 2020 | -0.29% |
| Jun 30, 2020 | -597.31% |
| Mar 31, 2020 | -188.79% |
| Dec 31, 2019 | 81.87% |
| Sep 30, 2019 | 39.23% |
| Jun 30, 2019 | 8.28% |
| Mar 31, 2019 | 3,044.00% |
| Dec 31, 2018 | 5.61% |
| Sep 30, 2018 | 30.10% |
| Jun 30, 2018 | -32.08% |
| Mar 31, 2018 | 96.68% |
| Dec 31, 2017 | -6.26% |
| Sep 30, 2017 | 694.08% |
| Jun 30, 2017 | 1,756.37% |
| Mar 31, 2017 | -0.67% |
| Dec 31, 2016 | 723.18% |
| Sep 30, 2016 | 17.36% |
| Jun 30, 2016 | 162.20% |